Ascendis Pharma AS (ASND)
126.51
+2.23
(+1.79%)
USD |
NASDAQ |
Nov 15, 16:00
126.56
+0.04
(+0.04%)
After-Hours: 20:00
Ascendis Pharma Shares Outstanding: 59.76M for Sept. 27, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
September 27, 2024 | 59.76M |
September 23, 2024 | 59.65M |
September 11, 2024 | 57.35M |
August 14, 2024 | 57.35M |
July 10, 2024 | 57.35M |
June 30, 2024 | 57.35M |
June 28, 2024 | 57.14M |
June 11, 2024 | 57.14M |
May 15, 2024 | 57.13M |
December 31, 2023 | 56.61M |
December 28, 2023 | 56.59M |
November 16, 2023 | 56.55M |
September 30, 2023 | 56.54M |
September 29, 2023 | 56.54M |
March 31, 2023 | 56.22M |
February 01, 2023 | 57.15M |
December 31, 2022 | 57.15M |
September 30, 2022 | 57.03M |
June 30, 2022 | 55.81M |
March 31, 2022 | 55.80M |
February 01, 2022 | 56.78M |
January 12, 2022 | 56.94M |
December 31, 2021 | 56.78M |
October 21, 2021 | 56.88M |
September 30, 2021 | 56.88M |
Date | Value |
---|---|
September 16, 2021 | 56.84M |
September 07, 2021 | 56.40M |
June 30, 2021 | 53.90M |
June 10, 2021 | 53.88M |
May 28, 2021 | 53.83M |
May 13, 2021 | 53.83M |
April 30, 2021 | 53.83M |
April 15, 2021 | 53.83M |
March 31, 2021 | 53.83M |
March 01, 2021 | 53.75M |
February 11, 2021 | 53.75M |
December 31, 2020 | 53.75M |
December 30, 2020 | 53.75M |
October 16, 2020 | 53.42M |
September 30, 2020 | 53.42M |
July 10, 2020 | 53.17M |
June 30, 2020 | 48.35M |
June 12, 2020 | 48.31M |
May 29, 2020 | 49.30M |
March 31, 2020 | 47.99M |
March 01, 2020 | 47.99M |
December 31, 2019 | 47.99M |
September 30, 2019 | 47.74M |
September 27, 2019 | 47.74M |
July 01, 2019 | 47.55M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
47.99M
Minimum
Dec 31 2019
59.76M
Maximum
Sep 27 2024
54.93M
Average
56.40M
Median
Sep 07 2021
Shares Outstanding Benchmarks
Novo Nordisk AS | 4.444B |
Evaxion Biotech AS | 5.578M |
Trinity Biotech PLC | 9.466M |
Biodexa Pharmaceuticals PLC | 0.5808M |
NuCana PLC | 2.246M |